Bartter syndrome natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 5: Line 5:
{{CMG}}{{AE}}{{TAM}}
{{CMG}}{{AE}}{{TAM}}
==Overview==
==Overview==
Bartter Syndrome usually occurs in childhood. [[Bartter syndrome]] type I and type II are salt-wasting renal tubular disorders that are clinically characterized by [[polyhydramnios]] leading to [[premature delivery]], marked [[polyuria]], and a tendency towards [[nephrocalcinosis]]. Common complications of [[Bartter syndrome]] include [[Gallstones]], [[Rhabdomyolysis]], [[Prolonged QT interval]], Life-threatening [[arrhythmia]], [[Syncope]], [[Sudden death]], weakening of the bones and Renal failure. The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic [[Bartter Syndrome]] (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained [[hypokalemia]] and [[hyperreninemia]] can cause progressive [[tubulointerstitial nephritis]], resulting in [[end-stage renal disease]] (Kidney failure). With the early treatment of the [[electrolyte]] imbalances, the prognosis for patients with Classic [[Bartter Syndrome]] is good. Patients with [[Bartter syndrome]] type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.
==Natural History==
==Natural History==
*Bartter Syndrome usually occurs in childhood. Patient presents with the history of:
*Bartter Syndrome usually occurs in childhood. Patient presents with the history of:
Line 24: Line 25:


==Prognosis==
==Prognosis==
*The prognosis is based on mutation or depends on the degree of the receptor dysfunction.<ref name="pmid26140272">{{cite journal| author=Al Shibli A, Narchi H| title=Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations. | journal=World J Methodol | year= 2015 | volume= 5 | issue= 2 | pages= 55-61 | pmid=26140272 | doi=10.5662/wjm.v5.i2.55 | pmc=4482822 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26140272  }} </ref>
*The prognosis is based on mutations or depends on the degree of the receptor dysfunction.<ref name="pmid26140272">{{cite journal| author=Al Shibli A, Narchi H| title=Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations. | journal=World J Methodol | year= 2015 | volume= 5 | issue= 2 | pages= 55-61 | pmid=26140272 | doi=10.5662/wjm.v5.i2.55 | pmc=4482822 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26140272  }} </ref>
*The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic [[Bartter Syndrome]] (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained [[hypokalemia]] and [[hyperreninemia]] can cause progressive [[tubulointerstitial nephritis]], resulting in [[end-stage renal disease]] (Kidney failure). With the early treatment of the [[electrolyte]] imbalances, the prognosis for patients with Classic [[Bartter Syndrome]] is good.
*The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic [[Bartter Syndrome]] (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained [[hypokalemia]] and [[hyperreninemia]] can cause progressive [[tubulointerstitial nephritis]], resulting in [[end-stage renal disease]] (Kidney failure). With the early treatment of the [[electrolyte]] imbalances, the prognosis for patients with Classic [[Bartter Syndrome]] is good.
*Patients with [[Bartter syndrome]] type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833  }} </ref>
*Patients with [[Bartter syndrome]] type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833  }} </ref>

Latest revision as of 20:17, 5 August 2020

Main article: Bartter syndrome

Bartter syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bartter syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bartter syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bartter syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bartter syndrome natural history, complications and prognosis

CDC on Bartter syndrome natural history, complications and prognosis

Bartter syndrome natural history, complications and prognosis in the news

Blogs on Bartter syndrome natural history, complications and prognosis

Directions to Hospitals Treating Bartter syndrome

Risk calculators and risk factors for Bartter syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]

Overview

Bartter Syndrome usually occurs in childhood. Bartter syndrome type I and type II are salt-wasting renal tubular disorders that are clinically characterized by polyhydramnios leading to premature delivery, marked polyuria, and a tendency towards nephrocalcinosis. Common complications of Bartter syndrome include Gallstones, Rhabdomyolysis, Prolonged QT interval, Life-threatening arrhythmia, Syncope, Sudden death, weakening of the bones and Renal failure. The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic Bartter Syndrome (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained hypokalemia and hyperreninemia can cause progressive tubulointerstitial nephritis, resulting in end-stage renal disease (Kidney failure). With the early treatment of the electrolyte imbalances, the prognosis for patients with Classic Bartter Syndrome is good. Patients with Bartter syndrome type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.

Natural History

Complications

Prognosis

  • The prognosis is based on mutations or depends on the degree of the receptor dysfunction.[8]
  • The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic Bartter Syndrome (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained hypokalemia and hyperreninemia can cause progressive tubulointerstitial nephritis, resulting in end-stage renal disease (Kidney failure). With the early treatment of the electrolyte imbalances, the prognosis for patients with Classic Bartter Syndrome is good.
  • Patients with Bartter syndrome type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.[3]

References

  1. "Bartter syndrome: MedlinePlus Medical Encyclopedia".
  2. Seyberth HW (2008). "An improved terminology and classification of Bartter-like syndromes". Nat Clin Pract Nephrol. 4 (10): 560–7. doi:10.1038/ncpneph0912. PMID 18695706.
  3. 3.0 3.1 3.2 Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F; et al. (2010). "Long-term follow-up of patients with Bartter syndrome type I and II". Nephrol Dial Transplant. 25 (9): 2976–81. doi:10.1093/ndt/gfq119. PMID 20219833.
  4. Hacihamdioglu DO, Fidanci K, Kilic A, Gok F, Topaloglu R (2013). "QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study". Pediatr Nephrol. 28 (10): 1969–74. doi:10.1007/s00467-013-2517-5. PMID 23760993.
  5. Scognamiglio R, Negut C, Calò LA (2007). "Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes". Clin Nephrol. 67 (3): 193–7. doi:10.5414/cnp67193. PMID 17390745.
  6. Reungjui S, Roncal CA, Sato W, Glushakova OY, Croker BP, Suga S; et al. (2008). "Hypokalemic nephropathy is associated with impaired angiogenesis". J Am Soc Nephrol. 19 (1): 125–34. doi:10.1681/ASN.2007030261. PMC 2391040. PMID 18178802.
  7. "Bartter syndrome - Genetics Home Reference - NIH".
  8. 8.0 8.1 Al Shibli A, Narchi H (2015). "Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations". World J Methodol. 5 (2): 55–61. doi:10.5662/wjm.v5.i2.55. PMC 4482822. PMID 26140272.


Template:WikiDoc Sources